Canertinib induces ototoxicity in three preclinical models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Canertinib induces ototoxicity in three preclinical models

Published:2015-10 Issue: Volume:328 Page:59-66
ISSN:0378-5955
Container-title:Hearing Research
language:en
Short-container-title:Hearing Research

Author:

Tang Jian,Qian Yi,Li Hui,Kopecky Benjamin J.,Ding Dalian,Ou Henry C.,DeCook Rhonda,Chen Xiaojie,Sun Zhenyu,Kobel Megan,Bao Jianxin

Funder

National Institute of Health

Publisher

Elsevier BV

Subject

Sensory Systems

Reference74 articles.

1. Role of neuregulins in glial cell development;Adlkofer;Glia,2000

2. Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders;Agustoni;Cancer Treat. Rev.,2014

3. The clinical implications of antitumor immunity in head and neck cancer;Allen;Laryngoscope,2012

4. CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer;Allen;Semin. Oncol.,2003

5. Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse;Almadori;Int. J. Cancer,1999

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nrg1/ErbB2 regulates differentiation and apoptosis of neural stem cells in the cochlear nucleus through PI3K/Akt pathway;Neuroscience Letters;2021-04

2. NRG/ErbB signaling regulates neonatal muscle growth but not neuromuscular contractures in neonatal brachial plexus injury;FEBS Letters;2021-01-28

3. Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity;Journal of the Association for Research in Otolaryngology;2021-01-07

4. Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology;Drug Safety;2019-01-16

5. Ascitic fluid from advanced ovarian cancer patients compromises the activity of receptor tyrosine kinase inhibitors in 3D cell clusters of ovarian cancer cells;Cancer Letters;2018-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3